You have reached the HIVandHepatitis.com legacy site. Please visit our new site at hivandhepatitis.com

HIVandHepatitis.com
 Google Custom Search

Hepatitis C - Hematological Disorders /
Neutropenia and Anemia

Anemia during Hepatitis C Treatment Predicts Sustained Response to Pegylated Interferon/ribavirin
1-11-2011

Viramidine Fails to Show Non-inferiority to Ribavirin at Tested Doses, but Causes Less Anemia
1-19-2010

Open Phase 3 Study of Eltrombopag for Raising Platelet Levels in Patients with Chronic Liver Disease and Thrombocytopenia

2-27-2009


Prodrug Taribavirin Produces Equivalent Response, but Less Anemia than Ribavirin at 48 Weeks
2-27-2008

Study Demonstrates Safety of Erythropoiesis-stimulating Agents for Managing Ribavirin-related Anemia in Hepatitis C Patients
7-29-2008


Taribavirin Efficacy Similar to Ribavirin in Combination Therapy for Hepatitis C, but with Less Anemia
5-09-2008